GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (OTCPK:CNADF) » Definitions » Other Operating Expense

CNADF (CanadaBis Capital) Other Operating Expense : $0.36 Mil (TTM As of Jan. 2025)


View and export this data going back to 2023. Start your Free Trial

What is CanadaBis Capital Other Operating Expense?

CanadaBis Capital's Other Operating Expense for the three months ended in Jan. 2025 was $0.07 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2025 was $0.36 Mil.

CanadaBis Capital's quarterly Other Operating Expense declined from Jul. 2024 ($0.10 Mil) to Oct. 2024 ($0.10 Mil) and declined from Oct. 2024 ($0.10 Mil) to Jan. 2025 ($0.07 Mil).

CanadaBis Capital's annual Other Operating Expense increased from Jul. 2022 ($0.24 Mil) to Jul. 2023 ($0.26 Mil) and increased from Jul. 2023 ($0.26 Mil) to Jul. 2024 ($0.39 Mil).


CanadaBis Capital Other Operating Expense Historical Data

The historical data trend for CanadaBis Capital's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital Other Operating Expense Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only 0.21 0.26 0.24 0.26 0.39

CanadaBis Capital Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.09 0.10 0.10 0.07

CanadaBis Capital Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital Other Operating Expense Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital Business Description

Traded in Other Exchanges
Address
255C Clearview Drive, Red Deer County, Red Deer, AB, CAN, T4E 3B6
CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.